Natural antibodies to polysaccharide capsules enable Kupffer cells to capture invading bacteria in the liver sinusoids
Journal of Experimental Medicine · 03.02.2025 · 222 (2)
DOI: 10.1084/jem.20240735 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 24.12.2024. Verfasst von Xianbin Tian und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Center for Infection Biology, Tsinghua University , Beijing, China. Hauptthemen laut MEDLINE: Kupffer Cells, Liver, Klebsiella pneumoniae, Streptococcus pneumoniae. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Tsinghua University Initiative Scientific Research Program.
Abstract (Originalsprache)
The interception of blood-borne bacteria in the liver defines the outcomes of invasive bacterial infections, but the mechanisms of this antibacterial immunity are not fully understood. This study shows that natural antibodies (nAbs) to capsules enable liver macrophage Kupffer cells (KCs) to rapidly capture and kill blood-borne encapsulated bacteria in mice. Affinity pulldown with serotype-10A capsular polysaccharides (CPS10A) of Streptococcus pneumoniae (Spn10A) led to the identification of CPS10A-binding nAbs in serum. The CPS10A–antibody interaction enabled KCs to capture Spn10A bacteria from the bloodstream, in part through complement receptors on KCs. The nAbs were found to recognize the β1-6-linked galactose branch of CPS10A and similar moieties of serotype-39 S. pneumoniae and serotype-K50 Klebsiella pneumoniae capsules. More importantly, the nAbs empowered KCs to capture serotype-39 S. pneumoniae and serotype-K50 K. pneumoniae in the liver. Collectively, our data have revealed a highly effective immune function of nAb against encapsulated bacteria and emphasize the concept of treating septic encapsulated bacterial diseases with monoclonal antibodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Center for Infection Biology, Tsinghua University , Beijing, China.
- Tsinghua-Peking Center for Life Sciences, Tsinghua University , Beijing, China.
- Institute of Medical Technology, Peking University Health Science Center , Beijing, China.
- Department of Microbiology and Infectious Disease Center, Peking University Health Science Center, Beijing, China.
- State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
ORCID-Profile: Xianbin Tian, Yanni Liu, Kun Zhu, Haoran An, Jie Feng, Linqi Zhang, Jing-Ren Zhang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Tsinghua University Initiative Scientific Research Program
Zitieren
APA
Tian, X., Liu, Y., Zhu, K., An, H., Feng, J., Zhang, L., & Zhang, J. R. (2025). Natural antibodies to polysaccharide capsules enable Kupffer cells to capture invading bacteria in the liver sinusoids. Journal of Experimental Medicine, 222(2). https://doi.org/10.1084/jem.20240735
Vancouver
Tian X, Liu Y, Zhu K, An H, Feng J, Zhang L, et al. Natural antibodies to polysaccharide capsules enable Kupffer cells to capture invading bacteria in the liver sinusoids. Journal of Experimental Medicine. 2025;222(2). doi:10.1084/jem.20240735
BibTeX
@article{Tian2025,
author = {Tian, Xianbin and Liu, Yanni and Zhu, Kun and An, Haoran and Feng, Jie and Zhang, Linqi and Zhang, Jing-Ren},
title = {Natural antibodies to polysaccharide capsules enable Kupffer cells to capture invading bacteria in the liver sinusoids},
journal = {Journal of Experimental Medicine},
year = {2025},
volume = {222},
number = {2},
doi = {10.1084/jem.20240735}
}
EUVIMED